Although deficiency of each gene shows similar clinical and cellular phenotypes, ∼60% of Fanconi anemia patients presented defective FANCA (9,15), indicating that this protein may have additional biological functions beyond the canonical pathway through FANCI-FANCD2 monoubiquitination. This evidence concerns the gene FANCD2 and Fanconi anemia.